ArticleJournal of pharmaceutical health care and sciences2026

Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database.

Nao Takatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.